AI
Friday, March 07, 2014 10:03:12 PM
Yeah we are snakebit. 
I wasn't too impressed with the the CC although I only read the the transcript. As far as the buyback I 'm not a fan. If we had great managment they will deploy the assets accordingly to get us a return. The BB may work in the short term but its cash out the door and if I was the CFO I would have hard time rationalizing it. This likely response to shareholder letter made public last month. It could be they got railroaded into it.
Earnings were nothing to write home about although I'll take anything that supports the PE. I didn't see the immediate synergy of the molecule deal...hopefully later but seems to be the company is now based offshore which is another negative for me.
I wasn't too impressed with the the CC although I only read the the transcript. As far as the buyback I 'm not a fan. If we had great managment they will deploy the assets accordingly to get us a return. The BB may work in the short term but its cash out the door and if I was the CFO I would have hard time rationalizing it. This likely response to shareholder letter made public last month. It could be they got railroaded into it. Earnings were nothing to write home about although I'll take anything that supports the PE. I didn't see the immediate synergy of the molecule deal...hopefully later but seems to be the company is now based offshore which is another negative for me.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
